ArticlePloS one2017

The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling.

Inna Gordiienko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.